I have literally spent hours and hours teasing through similar complicated drugs and previous decisions and over time have become more and more confident that this will be approved and has to be approved if the FDA is going to be consistent with past approvals. Obviously I can’t speak for them or know what they will do until they do it. But I don’t see them rejecting DCVax-L. I think that is entirely unlikely. But that’s just my opinion, and everyone needs to do their own due diligence.
Market Data 
Markets 
AI
